These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12968606)

  • 1. [Results of clinical evidence: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)].
    Liakishev AA;
    Kardiologiia; 2003; 43(4):61-2. PubMed ID: 12968606
    [No Abstract]   [Full Text] [Related]  

  • 2. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diuretics vs alpha-blockers for treatment of hypertension: lessons from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Lasagna L
    JAMA; 2000 Apr; 283(15):2013-4. PubMed ID: 10789671
    [No Abstract]   [Full Text] [Related]  

  • 4. High praise for an old standby. Low-cost diuretics excel in combating high blood pressure.
    Heart Advis; 2003 Mar; 6(3):3. PubMed ID: 12703455
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Old or new antihypertensive drugs? Consequences from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial].
    Düsing R
    Dtsch Med Wochenschr; 2003 Jan; 128(5):214-6. PubMed ID: 12557115
    [No Abstract]   [Full Text] [Related]  

  • 7. National Heart, Lung, and Blood Institute halts part of antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
    SoRelle R
    Circulation; 2000 Mar; 101(12):E9025. PubMed ID: 10736305
    [No Abstract]   [Full Text] [Related]  

  • 8. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.
    Davis BR; Cutler JA; Gordon DJ; Furberg CD; Wright JT; Cushman WC; Grimm RH; LaRosa J; Whelton PK; Perry HM; Alderman MH; Ford CE; Oparil S; Francis C; Proschan M; Pressel S; Black HR; Hawkins CM
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):342-60. PubMed ID: 8722437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Are all antihypertensive agents equal? Cardiovascular events in hypertensive patients randomized to treatment with doxazosin or chlorthalidone. The ALLHAT study].
    Schillaci G; Verdecchia P
    Ital Heart J Suppl; 2000 Sep; 1(9):1215-7. PubMed ID: 11140297
    [No Abstract]   [Full Text] [Related]  

  • 10. Atorvastatin and amlodipine co-treatment in ASCOT--LLA shows benefit.
    Cardiovasc J S Afr; 2007; 18(1):43-4. PubMed ID: 17392998
    [No Abstract]   [Full Text] [Related]  

  • 11. What are the best first-line antihypertensives: answers and more questions from the ALLHAT study.
    Salam AM
    Expert Opin Investig Drugs; 2003 May; 12(5):879-85. PubMed ID: 12720498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group
    Hypertension; 2003 Sep; 42(3):239-46. PubMed ID: 12925554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
    Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chlorthalidone and diltiazem on myocardial ischemia in elderly patients with hypertension and coronary artery disease.
    Serro-Azul JB; de Paula RS; Gruppi C; Pinto L; Pierri H; Nussbacher A; Gebara O; Moffa P; Pereira-Barreto AC; Wajngarten M
    Arq Bras Cardiol; 2001 Apr; 76(4):268-72. PubMed ID: 11323730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ALLHAT Trial. Diuretics are still the preferred initial drugs for high blood pressure.
    Vidt DG
    Cleve Clin J Med; 2003 Mar; 70(3):263-9. PubMed ID: 12678218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective.
    Ernst ME; Carter BL; Basile JN
    J Clin Hypertens (Greenwich); 2009 Jan; 11(1):5-10. PubMed ID: 19125852
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypertension combined with atherosclerotic lesions in carotid arteries: should angiotensin converting enzyme inhibitors be prescribed?].
    Fomin VV; Moiseev SV
    Kardiologiia; 2005; 45(12):99-102. PubMed ID: 16353055
    [No Abstract]   [Full Text] [Related]  

  • 18. Implications of discontinuation of doxazosin arm of ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Messerli FH
    Lancet; 2000 Mar; 355(9207):863-4. PubMed ID: 10752699
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U;
    Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The ALLHAT study: contributions, limitations and prospectives].
    Mancia G
    Ital Heart J Suppl; 2003 Feb; 4(2):77-84. PubMed ID: 12762256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.